Private Hospital Sealed After Woman, Child Die During Delivery In Fazilka

Fazilka : Dr Karamjeet Singh, practising at a private hospital in Arniwala sub-tehsil of Fazilka district, has been booked under Section 304 (causing death by negligence) of the IPC today as a pregnant woman and her child died during a delivery procedure on June 5.

The relatives of the deceased and a large number of villagers had been staging a protest by blocking the Fazilka-Malout road since Tuesday, demanding the registration of a murder case under Section 302 of the IPC against the doctor.

They were also seeking the registration of an FIR against Medical Officer (surgeon) Dr Kirti, posted at the Community Health Centre (CHC) in Dabwala Kalan village, who had referred the patient to the private hospital.

The protesters had kept the body of the deceased woman at the protest site. They lifted the dharna after Dr Babita, officiating Civil Surgeon, said Dr Kriti had been placed under suspension.

Meharban Singh said he had taken his pregnant wife Veerpal Kaur to the CHC on June 5 and a surgeon informed them that a delivery could not be performed there. The surgeon referred them to the private hospital and she, accompanied by Nachhatar Singh, took them there.

Dr Babita said the operation theatre and the hospital of Dr Karamjeet had been sealed. She said disciplinary action had been recommended against the surgeon and a three-member enquiry committee had been constituted.

Notably, the name of Dr Kirti figures in the FIR but no section of the IPC has been imposed on her on plea that criminal action shall be taken after the outcome of the enquiry being conducted by the Health Department.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad